Compare $ENOV vs $PRCT | Chartloom

Compare

$ENOV vs $PRCT

Enovis Corp · Procept Biorobotics Corp

ENOV

Enovis Corp

PRCT

Procept Biorobotics Corp

Compare $ENOV vs $PRCT

Comparing Enovis Corp and Procept Biorobotics Corp

ENOVEnovis Corp

PRCTProcept Biorobotics Corp

ENOVEnovis Corp

Market cap

$1.02B

P/E (TTM)

—

Forward P/E (NTM)

4.57x

Forward P/S (NTM)

0.41x

Rev growth (TTM)

4.9%

YTD performance

-33.3%

52W performance

-44.3%

FCF yield

6.3%

PRCTProcept Biorobotics Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.35x

Rev growth (TTM)

22.7%

YTD performance

-40.2%

52W performance

-47.1%

FCF yield

-8.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ENOV

PRCT

Detailed metrics comparison

ENOV

Enovis Corp

PRCT

Procept Biorobotics Corp

Market Cap

ENOV$1.02B

PRCT$1.05B

Enterprise Value

ENOV$2.29B

PRCT$871M

Price

ENOV$17.69

PRCT$18.40

P/E Ratio

ENOVN/A

PRCTN/A

P/S Ratio

ENOV0.44x

PRCT3.10x

EV/Sales

ENOV1.00x

PRCT2.58x

EV/EBITDA

ENOV5.92x

PRCT0.00x

P/B Ratio

ENOV0.69x

PRCT2.89x

P/FCF Ratio

ENOV16.00x

PRCTN/A

EV/FCF

ENOV35.98x

PRCT-10.26x

PEG Ratio

ENOVN/A

PRCTN/A

Forward P/E (NTM)

ENOV4.57x

PRCTN/A

Forward P/S (NTM)

ENOV0.41x

PRCT2.35x

Revenue (TTM)

ENOV$2.30B

PRCT$337M

Revenue Growth (YoY)

ENOV4.9%

PRCT22.7%

Forward Rev Growth

ENOV4.9%

PRCT20.6%

Gross Margin (TTM)

ENOV61.4%

PRCT64.2%

Operating Margin (TTM)

ENOV0.0%

PRCT0.0%

EBITDA Margin (TTM)

ENOV16.9%

PRCT-31.8%

Net Margin (TTM)

ENOV-48.0%

PRCT-32.5%

FCF Margin (TTM)

ENOV2.8%

PRCT-25.2%

Net Income (TTM)

ENOV$-1.10B

PRCT$-110M

FCF (TTM)

ENOV$64M

PRCT$-85M

EPS (TTM)

ENOV-$19.13

PRCT-$1.92

ROE (TTM)

ENOV-6817.0%

PRCT-3062.0%

ROA (TTM)

ENOV-2777.0%

PRCT-2211.0%

ROIC (TTM)

ENOV-3756.0%

PRCT-2676.0%

Cash

ENOV$13M

PRCT$228M

Debt

ENOV$1.28B

PRCT$52M

Net Cash/Debt

ENOV$-1.27B

PRCT$176M

Current Ratio (TTM)

ENOV1.98x

PRCT6.55x

Quick Ratio (TTM)

ENOV0.92x

PRCT5.23x

Debt/Equity (TTM)

ENOV0.87x

PRCT0.15x

Debt/Assets (TTM)

ENOV0.0%

PRCT0.0%

Interest Coverage (TTM)

ENOVN/A

PRCTN/A

Net Debt/EBITDA (TTM)

ENOV0.00x

PRCT0.00x

Beta

ENOV1.45

PRCT0.88

52W Performance

ENOV-44.3%

PRCT-47.1%

YTD Performance

ENOV-33.3%

PRCT-40.2%

% from 52W High

ENOV-48.4%

PRCT-51.7%

% from 52W Low

ENOV5.9%

PRCT10.4%

Asset Turnover (TTM)

ENOV0.58x

PRCT0.68x

FCF Yield (TTM)

ENOV6.3%

PRCT-8.1%

Earnings Yield (TTM)

ENOV-108.2%

PRCT-10.5%

Dividend Yield (TTM)

ENOVN/A

PRCTN/A

Rule of 40

ENOV7.7

PRCT-2.5

EV/GP/RG

ENOV0.19

PRCT0.12

Ticker research

View ENOV research View PRCT research

Metric	ENOV Enovis Corp	PRCT Procept Biorobotics Corp
Market & Valuation
Market Cap	$1.02B	$1.05B
Enterprise Value	$2.29B	$871M
Price	$17.69	$18.40
P/E Ratio	N/A	N/A
P/S Ratio	0.44x	3.10x
EV/Sales	1.00x	2.58x
EV/EBITDA	5.92x	0.00x
P/B Ratio	0.69x	2.89x
P/FCF Ratio	16.00x	N/A
EV/FCF	35.98x	-10.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	4.57x	N/A
Forward P/S (NTM)	0.41x	2.35x
Revenue & Growth
Revenue (TTM)	$2.30B	$337M
Revenue Growth (YoY)	4.9%	22.7%
Forward Rev Growth	4.9%	20.6%
Profitability
Gross Margin (TTM)	61.4%	64.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	16.9%	-31.8%
Net Margin (TTM)	-48.0%	-32.5%
FCF Margin (TTM)	2.8%	-25.2%
Net Income (TTM)	$-1.10B	$-110M
FCF (TTM)	$64M	$-85M
EPS (TTM)	-$19.13	-$1.92
ROE (TTM)	-6817.0%	-3062.0%
ROA (TTM)	-2777.0%	-2211.0%
ROIC (TTM)	-3756.0%	-2676.0%
Financial Health
Cash	$13M	$228M
Debt	$1.28B	$52M
Net Cash/Debt	$-1.27B	$176M
Current Ratio (TTM)	1.98x	6.55x
Quick Ratio (TTM)	0.92x	5.23x
Debt/Equity (TTM)	0.87x	0.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.88
52W Performance	-44.3%	-47.1%
YTD Performance	-33.3%	-40.2%
% from 52W High	-48.4%	-51.7%
% from 52W Low	5.9%	10.4%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	0.68x
FCF Yield (TTM)	6.3%	-8.1%
Earnings Yield (TTM)	-108.2%	-10.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	7.7	-2.5
EV/GP/RG	0.19	0.12
Ticker research	View ENOV research	View PRCT research

Valuation

P/S Ratio

ENOV

0.44x

PRCT

3.10x

EV/FCF

PRCT

-10.26x

ENOV

35.98x

Growth & revenue

Revenue Growth TTM

PRCT

22.7%

ENOV

4.9%

Forward Revenue Growth

PRCT

20.6%

ENOV

4.9%

Profitability & performance

Gross Margin

PRCT

64.2%

ENOV

61.4%

ROE

PRCT

-3062.0%

ENOV

-6817.0%

FCF Yield %

ENOV

6.3%

PRCT

-8.1%

52-Week Performance

ENOV

-44.3%

PRCT

-47.1%

Detailed metrics comparison

ENOV

Enovis Corp

PRCT

Procept Biorobotics Corp

Market Cap

ENOV$1.02B

PRCT$1.05B

Enterprise Value

ENOV$2.29B

PRCT$871M

Price

ENOV$17.69

PRCT$18.40

P/E Ratio

ENOVN/A

PRCTN/A

P/S Ratio

ENOV0.44x

PRCT3.10x

EV/Sales

ENOV1.00x

PRCT2.58x

EV/EBITDA

ENOV5.92x

PRCT0.00x

P/B Ratio

ENOV0.69x

PRCT2.89x

P/FCF Ratio

ENOV16.00x

PRCTN/A

EV/FCF

ENOV35.98x

PRCT-10.26x

PEG Ratio

ENOVN/A

PRCTN/A

Forward P/E (NTM)

ENOV4.57x

PRCTN/A

Forward P/S (NTM)

ENOV0.41x

PRCT2.35x

Revenue (TTM)

ENOV$2.30B

PRCT$337M

Revenue Growth (YoY)

ENOV4.9%

PRCT22.7%

Forward Rev Growth

ENOV4.9%

PRCT20.6%

Gross Margin (TTM)

ENOV61.4%

PRCT64.2%

Operating Margin (TTM)

ENOV0.0%

PRCT0.0%

EBITDA Margin (TTM)

ENOV16.9%

PRCT-31.8%

Net Margin (TTM)

ENOV-48.0%

PRCT-32.5%

FCF Margin (TTM)

ENOV2.8%

PRCT-25.2%

Net Income (TTM)

ENOV$-1.10B

PRCT$-110M

FCF (TTM)

ENOV$64M

PRCT$-85M

EPS (TTM)

ENOV-$19.13

PRCT-$1.92

ROE (TTM)

ENOV-6817.0%

PRCT-3062.0%

ROA (TTM)

ENOV-2777.0%

PRCT-2211.0%

ROIC (TTM)

ENOV-3756.0%

PRCT-2676.0%

Cash

ENOV$13M

PRCT$228M

Debt

ENOV$1.28B

PRCT$52M

Net Cash/Debt

ENOV$-1.27B

PRCT$176M

Current Ratio (TTM)

ENOV1.98x

PRCT6.55x

Quick Ratio (TTM)

ENOV0.92x

PRCT5.23x

Debt/Equity (TTM)

ENOV0.87x

PRCT0.15x

Debt/Assets (TTM)

ENOV0.0%

PRCT0.0%

Interest Coverage (TTM)

ENOVN/A

PRCTN/A

Net Debt/EBITDA (TTM)

ENOV0.00x

PRCT0.00x

Beta

ENOV1.45

PRCT0.88

52W Performance

ENOV-44.3%

PRCT-47.1%

YTD Performance

ENOV-33.3%

PRCT-40.2%

% from 52W High

ENOV-48.4%

PRCT-51.7%

% from 52W Low

ENOV5.9%

PRCT10.4%

Asset Turnover (TTM)

ENOV0.58x

PRCT0.68x

FCF Yield (TTM)

ENOV6.3%

PRCT-8.1%

Earnings Yield (TTM)

ENOV-108.2%

PRCT-10.5%

Dividend Yield (TTM)

ENOVN/A

PRCTN/A

Rule of 40

ENOV7.7

PRCT-2.5

EV/GP/RG

ENOV0.19

PRCT0.12

Ticker research

View ENOV research View PRCT research

Metric	ENOV Enovis Corp	PRCT Procept Biorobotics Corp
Market & Valuation
Market Cap	$1.02B	$1.05B
Enterprise Value	$2.29B	$871M
Price	$17.69	$18.40
P/E Ratio	N/A	N/A
P/S Ratio	0.44x	3.10x
EV/Sales	1.00x	2.58x
EV/EBITDA	5.92x	0.00x
P/B Ratio	0.69x	2.89x
P/FCF Ratio	16.00x	N/A
EV/FCF	35.98x	-10.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	4.57x	N/A
Forward P/S (NTM)	0.41x	2.35x
Revenue & Growth
Revenue (TTM)	$2.30B	$337M
Revenue Growth (YoY)	4.9%	22.7%
Forward Rev Growth	4.9%	20.6%
Profitability
Gross Margin (TTM)	61.4%	64.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	16.9%	-31.8%
Net Margin (TTM)	-48.0%	-32.5%
FCF Margin (TTM)	2.8%	-25.2%
Net Income (TTM)	$-1.10B	$-110M
FCF (TTM)	$64M	$-85M
EPS (TTM)	-$19.13	-$1.92
ROE (TTM)	-6817.0%	-3062.0%
ROA (TTM)	-2777.0%	-2211.0%
ROIC (TTM)	-3756.0%	-2676.0%
Financial Health
Cash	$13M	$228M
Debt	$1.28B	$52M
Net Cash/Debt	$-1.27B	$176M
Current Ratio (TTM)	1.98x	6.55x
Quick Ratio (TTM)	0.92x	5.23x
Debt/Equity (TTM)	0.87x	0.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.88
52W Performance	-44.3%	-47.1%
YTD Performance	-33.3%	-40.2%
% from 52W High	-48.4%	-51.7%
% from 52W Low	5.9%	10.4%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	0.68x
FCF Yield (TTM)	6.3%	-8.1%
Earnings Yield (TTM)	-108.2%	-10.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	7.7	-2.5
EV/GP/RG	0.19	0.12
Ticker research	View ENOV research	View PRCT research